Robotic Surgery in Oncology: Results From a Multidimensional Assessment in Italy
Speaker(s)
Tedesco D1, Gattuso D1, Colombo P1, Dotti A1, Toscano F1, Bellavia D2, Autelli G3, Foglia E3, Ferrario LB3
1ASST GOM Niguarda, Milano, Milano, Italy, 2LIUC University, Castellanza, VA, Italy, 3LIUC University, Castellanza, Italy
Presentation Documents
OBJECTIVES: To define the incremental benefits concerning a higher implementation of robotic surgery with respect to laparoscopy, assuming the hospital perspective, within the colorectal, gastric, esophageal, and pancreatic surgical settings.
METHODS: A Health Technology Assessment, grounded on the AdHopHTA framework, was conducted in 2023/2024. Different data sources were utilized: i) literature evidence, to define efficacy and safety comparative indicators, considering both surgical approaches; ii) real-world data, derived from a large-size Italian hospital, collecting anonymous hospital data flows to economically valorize the surgical pathways; and iii) healthcare professionals’ perceptions, defining the perceived added value of robotic versus laparoscopic surgery, based on an evaluation scale ranging from -3 to +3.
RESULTS: Literature declared a superimposable safety profile, despite a higher efficacy (% patients requiring a conversion to open surgery) emerged in most surgical settings.
From an economic perspective, an advantage is reported, except for gastric surgeries, leading to a general modification of costs per patient ranging from +7% to -9%. Over a 6-month time horizon, in the conduction of 131 surgical procedures, a higher use of robotic surgery would lead to a general hospital economic saving equal to 3% (-39,677 €), thus also generating significant organizational savings, in terms of reduction in the hospitalization days (-22%; -516 days). This feature would decrease the overall patients’ productivity loss by on average 26%. Healthcare professionals’ perceptions confirmed the superiority of robotic surgery, declaring a better occupational safety (0.60 vs -0.04, p-value=0.031) and effectiveness profile (1.62 vs -1.00, p-value=0.048). They also confirmed the potentialities of robotic surgery to improve patients’ satisfaction (2.33 vs 1.67, p-value=0.022), and to optimize both the patients’ post-operative pain (2.11 vs 1.33, p-value=0.033).CONCLUSIONS: Results showed the strategic relevance related to robotic surgery routinely implementation in the surgical practice, demonstrating its hospital economic and organizational sustainability, with important advantages for patients.
Code
HTA207
Topic
Study Approaches
Disease
Oncology, Surgery